|Bid||124.80 x 800|
|Ask||124.81 x 900|
|Day's Range||124.18 - 125.74|
|52 Week Range||100.34 - 129.70|
|Beta (5Y Monthly)||0.65|
|PE Ratio (TTM)||35.11|
|Earnings Date||Oct 19, 2021 - Oct 25, 2021|
|Forward Dividend & Yield||1.80 (1.44%)|
|Ex-Dividend Date||Oct 14, 2021|
|1y Target Est||132.05|
The U.S. government has agreed to purchase point-of care COVID-19 tests from Abbott Laboratories and Celltrion Inc to ship to nursing homes and other high risk populations as part of its broader plan to purchase $2 billion in rapid coronavirus tests, a person familiar with the matter said on Tuesday. The federal government will purchase tests as needed and has agreed to spend up to $626 million in its agreement with Celltrion and $554.4 million in its deal with Abbott, the person said.
Abbott's (ABT) Portico with FlexNav TAVR system is intended to treat people with symptomatic severe aortic stenosis who are at high or extreme risk for open-heart surgery.
Billionaire Jared Isaacman, who paid for the SpaceX Inspiration4 flight, pledged $100 million St. Jude Children's Research Hospital and set a goal of raising an additional $100 million by February 2022.